Application of cas: 132680-54-7 | Liu, Jiang et al. published an article in 2014

The crystal structure of 6-Methoxyisoindolin-1-one(cas:132680-54-7 SDS of cas: 132680-54-7) has been determined using x-ray crystallography and cell studies. It was found that 6-Methoxyisoindolin-1-one inhibits the interactions of chk1 with substructures of DNA, such as the major groove and minor groove.

Liu, Jiang;Wang, Luyao;Guo, Na;Teng, Yu-Ou;Yu, Peng published 《Design, synthesis and biological evaluation of the novel isoindolinone derivatives》 in 2014. The article was appeared in 《Journal of Chemical and Pharmaceutical Research》. They have made some progress in their research.SDS of cas: 132680-54-7 The article mentions the following:

A series of novel isoindolinone derivatives I [R = morpholino, pyrrolidino, N-Boc-piperazino, piperazino] were designed, synthesized and screened for their antitumor activity against HT-29, K562 and HepG2 cell lines. Among the tested compounds, isoindolinone derivative I [R = N-Boc-piperazino] exhibited good antitumor activity against HepG2 cancer cell line with IC50 of 5.89 μM. And 6-Methoxyisoindolin-1-one (cas: 132680-54-7) was used in the research process.

The crystal structure of 6-Methoxyisoindolin-1-one(cas:132680-54-7 SDS of cas: 132680-54-7) has been determined using x-ray crystallography and cell studies. It was found that 6-Methoxyisoindolin-1-one inhibits the interactions of chk1 with substructures of DNA, such as the major groove and minor groove.

Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Explore more uses of cas: 132680-54-7 | Daiichi Yakka Daigaku Kenkyu Nenpo

The crystal structure of 6-Methoxyisoindolin-1-one(cas:132680-54-7 Related Products of 132680-54-7) has been determined using x-ray crystallography and cell studies. It was found that 6-Methoxyisoindolin-1-one inhibits the interactions of chk1 with substructures of DNA, such as the major groove and minor groove.

Kamochi, Yasuko;Watanabe, Yasuo published 《Synthesis of isoindolinones by the amidomethylation of N-(hydroxymethyl)benzamides with pyrophosphoric acid》 in 1989. The article was appeared in 《Daiichi Yakka Daigaku Kenkyu Nenpo》. They have made some progress in their research.Related Products of 132680-54-7 The article mentions the following:

Synthesis of 1-isoindolinones by amidomethylation of N-(hydroxymethyl)benzamides with an electron-donating group para to the ring-closure site with pyrophosphoric acid is described, and a conversion of some amidomethylated intermediates into 1-isoindolinones is discussed. The experimental procedure involved many compounds, such as 6-Methoxyisoindolin-1-one (cas: 132680-54-7) .

The crystal structure of 6-Methoxyisoindolin-1-one(cas:132680-54-7 Related Products of 132680-54-7) has been determined using x-ray crystallography and cell studies. It was found that 6-Methoxyisoindolin-1-one inhibits the interactions of chk1 with substructures of DNA, such as the major groove and minor groove.

Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Application of cas: 132680-54-7 | Shen, Zhongqi et al. published an article in 2010

The crystal structure of 6-Methoxyisoindolin-1-one(cas:132680-54-7 Category: indole-building-block) has been determined using x-ray crystallography and cell studies. It was found that 6-Methoxyisoindolin-1-one inhibits the interactions of chk1 with substructures of DNA, such as the major groove and minor groove.

Category: indole-building-blockIn 2010, Shen, Zhongqi;Siva Ramamoorthy, P.;Hatzenbuhler, Nicole T.;Evrard, Deborah A.;Childers, Wayne;Harrison, Boyd L.;Chlenov, Michael;Hornby, Geoffrey;Smith, Deborah L.;Sullivan, Kelly M.;Schechter, Lee E.;Andree, Terrance H. published 《Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT1A receptor and the serotonin transporter》. 《Bioorganic & Medicinal Chemistry Letters》published the findings. The article contains the following contents:

The structure-activity relationship (SAR) for three series of lactam-fused chroman derivatives possessing 3-amino substituents was evaluated. Many compounds exhibited affinities for both the 5-HT1A receptor and the 5-HT transporter. I [R = F, CN] demonstrated 5-HT1A antagonist activities in the in vitro cAMP turnover model.6-Methoxyisoindolin-1-one (cas: 132680-54-7) were involved in the experimental procedure.

The crystal structure of 6-Methoxyisoindolin-1-one(cas:132680-54-7 Category: indole-building-block) has been determined using x-ray crystallography and cell studies. It was found that 6-Methoxyisoindolin-1-one inhibits the interactions of chk1 with substructures of DNA, such as the major groove and minor groove.

Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Gesmundo, Nathan J. et al. published new experimental results with the assistance of cas: 132680-54-7

6-Methoxyisoindolin-1-one(cas:132680-54-7 Computed Properties of C9H9NO2) is a class III topoisomerase inhibitor that binds to the chk1 protein, which is an enzyme involved in DNA replication. 6-Methoxyisoindolin-1-one inhibits the interaction between the chk1 protein and DNA, preventing DNA replication.

Computed Properties of C9H9NO2《Nanoscale synthesis and affinity ranking》 was published in 2018. The authors were Gesmundo, Nathan J.;Sauvagnat, Berengere;Curran, Patrick J.;Richards, Matthew P.;Andrews, Christine L.;Dandliker, Peter J.;Cernak, Tim, and the article was included in《Nature (London, United Kingdom)》. The author mentioned the following in the article:

Most drugs are developed through iterative rounds of chem. synthesis and biochem. testing to optimize the affinity of a particular compound for a protein target of therapeutic interest. This process is challenging because candidate mols. must be selected from a chem. space of more than 1060 drug-like possibilities1, and a single reaction used to synthesize each mol. has more than 107 plausible permutations of catalysts, ligands, additives and other parameters2. The merger of a method for high-throughput chem. synthesis with a biochem. assay would facilitate the exploration of this enormous search space and streamline the hunt for new drugs and chem. probes. Miniaturized high-throughput chem. synthesis3-7 has enabled rapid evaluation of reaction space, but so far the merger of such syntheses with bioassays has been achieved with only low-d. reaction arrays, which analyze only a handful of analogs prepared under a single reaction condition8-13. High-d. chem. synthesis approaches that have been coupled to bioassays, including on-bead14, on-surface15, on-DNA16 and mass-encoding technologies17, greatly reduce material requirements, but they require the covalent linkage of substrates to a potentially reactive support, must be performed under high dilution and must operate in a mixture format. These reaction attributes limit the application of transition-metal catalysts, which are easily poisoned by the many functional groups present in a complex mixture, and of transformations for which the kinetics require a high concentration of reactant. Here the authors couple high-throughput nanomole-scale synthesis with a label-free affinity-selection mass spectrometry bioassay. Each reaction is performed at a 0.1-M concentration in a discrete well to enable transition-metal catalysis while consuming less than 0.05 mg of substrate per reaction. The affinity-selection mass spectrometry bioassay is then used to rank the affinity of the reaction products to target proteins, removing the need for time-intensive reaction purification This method enables the primary synthesis and testing steps that are critical to the invention of protein inhibitors to be performed rapidly and with minimal consumption of starting materials. And 6-Methoxyisoindolin-1-one (cas: 132680-54-7) was used in the research process.

6-Methoxyisoindolin-1-one(cas:132680-54-7 Computed Properties of C9H9NO2) is a class III topoisomerase inhibitor that binds to the chk1 protein, which is an enzyme involved in DNA replication. 6-Methoxyisoindolin-1-one inhibits the interaction between the chk1 protein and DNA, preventing DNA replication.

Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Explore more uses of cas: 132680-54-7 | Tetrahedron

6-Methoxyisoindolin-1-one(cas:132680-54-7 Quality Control of 6-Methoxyisoindolin-1-one) is a class III topoisomerase inhibitor that binds to the chk1 protein, which is an enzyme involved in DNA replication. 6-Methoxyisoindolin-1-one inhibits the interaction between the chk1 protein and DNA, preventing DNA replication.

Lopez-Valdez, German;Olguin-Uribe, Simon;Millan-Ortiz, Alejandra;Gamez-Montano, Rocio;Miranda, Luis D. published 《Convenient access to isoindolinones via carbamoyl radical cyclization: Synthesis of cichorine and 4-hydroxyisoindolin-1-one natural products》 in 2011. The article was appeared in 《Tetrahedron》. They have made some progress in their research.Quality Control of 6-Methoxyisoindolin-1-one The article mentions the following:

An efficient and convenient access to 2-tert-butylisoindolin-1-ones via an oxidative radical cyclization process from stable carbamoylxanthates, derived from secondary tert-butylamines, is described. The proposed mechanism for this transformation involves, the generation of a carbamoyl radical, its cyclization to the aromatic system, and the dilauroyl peroxide (DLP) mediated rearomatization to generate the isoindolinone ring system. Addnl., the syntheses of cichorine and 4-hydroxyisoindolin-1-one natural products were carried out to underscore the synthetic potential of this xanthate-based carbamoyl radical-oxidative cyclization. And 6-Methoxyisoindolin-1-one (cas: 132680-54-7) was used in the research process.

6-Methoxyisoindolin-1-one(cas:132680-54-7 Quality Control of 6-Methoxyisoindolin-1-one) is a class III topoisomerase inhibitor that binds to the chk1 protein, which is an enzyme involved in DNA replication. 6-Methoxyisoindolin-1-one inhibits the interaction between the chk1 protein and DNA, preventing DNA replication.

Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Chang, Zhe et al. published new progress in experiments with the help of cas: 132680-54-7

6-Methoxyisoindolin-1-one(cas:132680-54-7 Recommanded Product: 6-Methoxyisoindolin-1-one) also interacts with inhibitors of other topoisomerases such as camptothecin and etoposide. It has been shown that combining these two drugs can inhibit cancer cells more effectively than either drug alone.

Recommanded Product: 6-Methoxyisoindolin-1-oneIn 2021, Chang, Zhe;Huang, Jialin;Wang, Si;Chen, Geshuyi;Zhao, Heng;Wang, Rui;Zhao, Depeng published 《Copper catalyzed late-stage C(sp3)-H functionalization of nitrogen heterocycles》. 《Nature Communications》published the findings. The article contains the following contents:

A copper-catalyzed late-stage C(sp3)-H functionalization of N-heterocycles using com. available catalysts under mild reaction conditions was reported. We have investigated eight types of N-heterocycles such as I (R = H, Me) which were usually found in medicinally important skeletons. The scope and utility of this approach were demonstrated by late-stage C(sp3)-H modification of these heterocycles including a number of pharmaceuticals with a broad range of nucleophiles, such as methylation, arylation, azidination, mono-deuteration, and glycoconjugation. Preliminary mechanistic studies revealed that the reaction undergoes a C-H fluorination process which is followed by a nucleophilic substitution. To complete the study, the researchers used 6-Methoxyisoindolin-1-one (cas: 132680-54-7) .

6-Methoxyisoindolin-1-one(cas:132680-54-7 Recommanded Product: 6-Methoxyisoindolin-1-one) also interacts with inhibitors of other topoisomerases such as camptothecin and etoposide. It has been shown that combining these two drugs can inhibit cancer cells more effectively than either drug alone.

Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Application of cas: 132680-54-7 | Wang, Ze-Shu et al. published an article in 2020

6-Methoxyisoindolin-1-one(cas:132680-54-7 Product Details of 132680-54-7) also interacts with inhibitors of other topoisomerases such as camptothecin and etoposide. It has been shown that combining these two drugs can inhibit cancer cells more effectively than either drug alone.

Wang, Ze-Shu;Chen, Yang-Bo;Zhang, Hao-Wen;Sun, Zhou;Zhu, Chunyin;Ye, Long-Wu published 《Ynamide Smiles Rearrangement Triggered by Visible-Light-Mediated Regioselective Ketyl-Ynamide Coupling: Rapid Access to Functionalized Indoles and Isoquinolines》. The research results were published in《Journal of the American Chemical Society》 in 2020.Product Details of 132680-54-7 The article conveys some information:

Here, a novel and practical radical Smiles rearrangement triggered by photoredox-catalyzed regioselective ketyl-ynamide coupling is reported, which represents the first radical Smiles rearrangement of ynamides. This method enables facile access to a variety of valuable 2-benzhydrylindoles with broad substrate scope in generally good yields under mild reaction conditions. In addition, this chem. can also be extended to the divergent synthesis of versatile 3-benzhydrylisoquinolines through a similar ketyl-ynamide coupling and radical Smiles rearrangement, followed by dehydrogenative oxidation Moreover, such an ynamide Smiles rearrangement initiated by intermol. photoredox catalysis via addition of external radical sources is also achieved. By control experiments, the reaction was shown to proceed via key ketyl radical and α-imino carbon radical intermediates. To complete the study, the researchers used 6-Methoxyisoindolin-1-one (cas: 132680-54-7) .

6-Methoxyisoindolin-1-one(cas:132680-54-7 Product Details of 132680-54-7) also interacts with inhibitors of other topoisomerases such as camptothecin and etoposide. It has been shown that combining these two drugs can inhibit cancer cells more effectively than either drug alone.

Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Application of cas: 132680-54-7 | Zhang, Chunhui et al. published an article in 2018

6-Methoxyisoindolin-1-one(cas:132680-54-7 Electric Literature of C9H9NO2) also interacts with inhibitors of other topoisomerases such as camptothecin and etoposide. It has been shown that combining these two drugs can inhibit cancer cells more effectively than either drug alone.

Electric Literature of C9H9NO2《Palladium-Catalyzed Direct C-H Carbonylation of Free Primary Benzylamines: A Synthesis of Benzolactams》 was published in 2018. The authors were Zhang, Chunhui;Ding, Yongzheng;Gao, Yuzhen;Li, Shangda;Li, Gang, and the article was included in《Organic Letters》. The author mentioned the following in the article:

A protocol for palladium-catalyzed C-H carbonylation of readily available free primary benzylamines using NH2 as the chelating group under an atm. pressure of CO has been achieved, providing a general, atom- and step-economic approach to benzolactams, an important structural motif found in many biol. active compounds Application of this new method is also exemplified in the concise syntheses of two bioactive mols, e.g., (R)-PD 172939. The experimental procedure involved many compounds, such as 6-Methoxyisoindolin-1-one (cas: 132680-54-7) .

6-Methoxyisoindolin-1-one(cas:132680-54-7 Electric Literature of C9H9NO2) also interacts with inhibitors of other topoisomerases such as camptothecin and etoposide. It has been shown that combining these two drugs can inhibit cancer cells more effectively than either drug alone.

Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles